PL2609149T3 - Wysoce biokompatybilne podwójne termożelujące kompozycje chitozan/sól glukozaminy - Google Patents

Wysoce biokompatybilne podwójne termożelujące kompozycje chitozan/sól glukozaminy

Info

Publication number
PL2609149T3
PL2609149T3 PL11819239T PL11819239T PL2609149T3 PL 2609149 T3 PL2609149 T3 PL 2609149T3 PL 11819239 T PL11819239 T PL 11819239T PL 11819239 T PL11819239 T PL 11819239T PL 2609149 T3 PL2609149 T3 PL 2609149T3
Authority
PL
Poland
Prior art keywords
salt compositions
highly biocompatible
glucosamine salt
thermogelling chitosan
chitosan
Prior art date
Application number
PL11819239T
Other languages
English (en)
Inventor
Abdellatif Chenite
Amine Selmani
Original Assignee
Oligo Medic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oligo Medic Inc filed Critical Oligo Medic Inc
Publication of PL2609149T3 publication Critical patent/PL2609149T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
    • C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
    • C08J3/075—Macromolecular gels
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2305/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
    • C08J2305/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Polymers & Plastics (AREA)
  • Surgery (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Composite Materials (AREA)
  • Materials Engineering (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Dental Preparations (AREA)
PL11819239T 2010-08-27 2011-08-26 Wysoce biokompatybilne podwójne termożelujące kompozycje chitozan/sól glukozaminy PL2609149T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US37759210P 2010-08-27 2010-08-27
US201161444646P 2011-02-18 2011-02-18
PCT/CA2011/000971 WO2012024785A1 (en) 2010-08-27 2011-08-26 Highly biocompatible dual thermogelling chitosan/glucosamine salt compositions
EP11819239.2A EP2609149B1 (en) 2010-08-27 2011-08-26 Highly biocompatible dual thermogelling chitosan/glucosamine salt compositions

Publications (1)

Publication Number Publication Date
PL2609149T3 true PL2609149T3 (pl) 2016-04-29

Family

ID=45722787

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11819239T PL2609149T3 (pl) 2010-08-27 2011-08-26 Wysoce biokompatybilne podwójne termożelujące kompozycje chitozan/sól glukozaminy

Country Status (13)

Country Link
EP (1) EP2609149B1 (pl)
JP (1) JP5898682B2 (pl)
CN (1) CN103189435B (pl)
AU (1) AU2011293055B2 (pl)
BR (1) BR112013004529B1 (pl)
CA (1) CA2808872C (pl)
DK (1) DK2609149T3 (pl)
EA (1) EA024569B1 (pl)
ES (1) ES2552659T3 (pl)
IL (1) IL224844A (pl)
PL (1) PL2609149T3 (pl)
PT (1) PT2609149E (pl)
WO (1) WO2012024785A1 (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6807099B2 (ja) * 2016-09-07 2021-01-06 公立大学法人大阪 生体活性セメントペーストおよび生体活性セメントを製造するためのキット、生体活性セメントペーストおよびその製造方法
WO2018187594A2 (en) * 2017-04-07 2018-10-11 View Point Medical, Inc. Multi-mode imaging markers
US12636402B2 (en) 2017-12-29 2026-05-26 Tricol Biomedical, Inc. Chitosan dressing for control of gastrointestinal bleeding
CN111787892B (zh) * 2017-12-29 2025-02-18 金珂生物医疗公司 抵抗溶解的组织粘附脱乙酰壳多糖材料
US11660236B2 (en) 2017-12-29 2023-05-30 Tricol Biomedical, Inc. Delivery systems for control of bleeding in transurethral prostatectomy
US12156791B2 (en) 2017-12-29 2024-12-03 Tricol Biomedical, Inc. Chitosan dressing for control of bleeding in transurethral prostatectomy
WO2021041560A1 (en) 2019-08-28 2021-03-04 View Point Medical, Inc. Ultrasound marker detection, markers and associated systems, methods and articles
US11882992B2 (en) 2019-11-27 2024-01-30 View Point Medical, Inc. Composite tissue markers detectable via multiple detection modalities including radiopaque element
US11903767B2 (en) 2019-11-27 2024-02-20 View Point Medical, Inc. Composite tissue markers detectable via multiple detection modalities
KR102212669B1 (ko) * 2020-04-29 2021-02-05 (주)바이오다인 알코올계 용액 조성물의 젤리화를 이용한 세포 검사 방법
KR102684221B1 (ko) * 2022-01-07 2024-07-10 충남대학교산학협력단 고치환도 키토산 유도체를 이용한 3d 바이오프린팅용 바이오잉크 조성물의 제조방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2299687C (en) * 1997-08-04 2009-10-27 Bio Syntech Ltd. Temperature-controlled ph-dependant formation of ionic polysaccharide gels
CA2212300A1 (en) * 1997-08-04 1999-02-04 Abdellatif Chenite In vitro or in vivo gelfying chitosan and therapeutic uses thereof
AU1375301A (en) * 1999-11-15 2001-05-30 Bio Syntech Canada Inc Temperature-controlled and ph-dependant self-gelling biopolymeric aqueous solution
DK1294414T3 (da) * 2000-06-29 2006-07-24 Biosyntech Canada Inc Præparat og fremgangsmåde til heling og regenerering af brusk og andre væv
JP4698932B2 (ja) * 2002-04-08 2011-06-08 肇一 柴 ポリリン酸と水溶性コラーゲンの複合体材料とその製造方法
CA2628244A1 (en) * 2005-11-04 2007-05-10 Bio Syntech Canada Inc. Gel formation of polyelectrolyte aqueous solutions by thermally induced changes in ionization state

Also Published As

Publication number Publication date
EA201390220A1 (ru) 2013-11-29
JP5898682B2 (ja) 2016-04-06
WO2012024785A1 (en) 2012-03-01
DK2609149T3 (en) 2015-11-23
EP2609149A1 (en) 2013-07-03
EP2609149B1 (en) 2015-08-12
ES2552659T3 (es) 2015-12-01
PT2609149E (pt) 2015-11-20
BR112013004529A8 (pt) 2018-01-02
CN103189435A (zh) 2013-07-03
BR112013004529B1 (pt) 2021-02-23
JP2013536024A (ja) 2013-09-19
EP2609149A4 (en) 2014-05-07
AU2011293055B2 (en) 2016-01-07
BR112013004529A2 (pt) 2016-08-16
HK1185370A1 (zh) 2014-02-14
EA024569B1 (ru) 2016-09-30
AU2011293055A1 (en) 2013-03-21
CA2808872A1 (en) 2012-03-01
CN103189435B (zh) 2016-02-17
CA2808872C (en) 2018-06-12
IL224844A (en) 2016-07-31

Similar Documents

Publication Publication Date Title
PT2609149E (pt) Composições de quitosano/sal de glucosamina termogelificantes duplas altamente biocompatíveis
ZA201303553B (en) Glucan compositions
IL222224A0 (en) Thermogelling anaesthetic compositions
ZA201305193B (en) Antimicrobial composition
ZA201208275B (en) Chitosan composition
ZA201300577B (en) Pet food compositions having antimicrobial activity
PL2461692T3 (pl) Synergistyczna kompozycja biobójcza
PL2461693T3 (pl) Synergistyczna kompozycja biobójcza
PL2458993T3 (pl) Synergistyczna kompozycja przeciwdrobnoustrojowa
GB2472315B (en) Antibacterial compositions
GB201008495D0 (en) Combines
EP2657244A4 (en) glycoside
EP2588060A4 (en) BIOACTIVE COMPOSITIONS
ZA201209604B (en) Chitosan powder
ZA201307018B (en) Antimicrobial composition
PL2467151T3 (pl) Przeciwbakteryjna kompozycja spożywcza
EP2688426A4 (en) SALT COMPOSITION WITH REDUCED SODIUM CONTENT
PT2563375E (pt) Composições farmacêuticas com agentes antimicrobianos de fosfónio
GB201002673D0 (en) Antimicrobial agent
PL2485588T3 (pl) Synergistyczna kompozycja biobójcza
PT2600720E (pt) Composições de tratamento pesticidas
GB201001632D0 (en) Antimicrobial compounds
ZA201403911B (en) Antimicrobial composition
GB201013150D0 (en) Antimicrobial compositions
GB201010944D0 (en) Antimicrobial compositions